The UK provides COVID-19 vaccine to people over the age of 45

People over the age of 45 can now book the UK Government’s COVID-19 vaccine Announcement on Tuesday.

At the House of Commons, Health Minister Matt Hancock said, “From today, we have released an invitation to vaccinate all people over the age of 45, and then vaccinated everyone over the age of 40, depending on the supply. We can officially announce that we will be vaccinated. ” ..

According to the Department of Health (DHSC), vaccines are provided to all of the government’s top nine priority groups (aged 50+, clinically vulnerable people, health care and social welfare workers).

“Currently, we are giving the first dose to more than 32 million people and we plan to provide the vaccine to all adults by the end of July,” Hancock said.

He said the vaccination program “saved more than 10,000 lives” and allowed the government to lift national blockade restrictions.

The Medicines and Healthcare Products Regulatory Agency (MHRA), the UK drug regulator, has so far approved three COVID-19 vaccines, Pfizer / BioNTech, Oxford / AstraZeneca, and Modernanajab.

Regulators are conducting rolling reviews to evaluate vaccine candidates manufactured by Janssen and Novabax.

According to Hancock, the deployment of the Modena vaccine in the United Kingdom began on April 7 in Wales and is now expanding to the United Kingdom.

Concerns that some variants of the CCP (Chinese Communist Party) virus, such as those first identified in South Africa and Brazil, are more resistant to antibodies than older variants and may reduce the effectiveness of the vaccine. had.

The DHSC said on Monday that it was conducting the UK’s “largest surge test operation” to date to curb the spread of South African variants in parts of South London.

Cases of the mutant virus have been confirmed since early March, mainly in the Onesworth and Lambeth autonomous regions. To date, 44 confirmed cases and 30 possible cases have been discovered.

There are some reports of adverse effects after vaccination. MHRA said on April 7, 19 people died in the UK after developing a rare blood clot after vaccination with AstraZeneca jab.

On the same day, the European Medicines Agency, the European Union’s drug regulatory body, said there was a “potential link” between the AstraZeneca vaccine and “very rare” blood clots.

However, both UK and EU regulators argued that the benefits of vaccination outweigh the risks.